share_log

CVS Health | 10-Q: Q2 2024 Earnings Report

CVS Health | 10-Q: Q2 2024 Earnings Report

西维斯健康 | 10-Q：2024财年二季报
美股SEC公告 ·  2024/08/07 18:41

Moomoo AI 已提取核心信息

CVS Health reported Q2 2024 total revenues increased 2.6% to $91.2 billion, driven by growth in Health Care Benefits and Pharmacy & Consumer Wellness segments, partially offset by declines in Health Services. Net income attributable to CVS Health decreased 6.9% to $1.77 billion, while diluted EPS was $1.41 compared to $1.48 in Q2 2023.The Health Care Benefits segment saw revenues rise 21.4% to $32.5 billion, though its medical benefit ratio increased to 89.6% from 86.2% due to higher utilization in Medicare Advantage and Medicaid. The Pharmacy & Consumer Wellness segment's revenues grew 3.7% to $29.8 billion, driven by increased prescription volume, while the Health Services segment revenues declined 8.8% to $42.2 billion following the loss of a large client.The company issued $5 billion in senior notes in May 2024 for general corporate purposes and repurchased 39.7 million shares for approximately $3 billion during H1 2024. CVS Health maintained its retail presence with over 9,000 locations and continued serving approximately 90 million pharmacy benefit manager plan members, though facing ongoing challenges from elevated Medicare utilization and Medicaid cost pressures.
CVS Health reported Q2 2024 total revenues increased 2.6% to $91.2 billion, driven by growth in Health Care Benefits and Pharmacy & Consumer Wellness segments, partially offset by declines in Health Services. Net income attributable to CVS Health decreased 6.9% to $1.77 billion, while diluted EPS was $1.41 compared to $1.48 in Q2 2023.The Health Care Benefits segment saw revenues rise 21.4% to $32.5 billion, though its medical benefit ratio increased to 89.6% from 86.2% due to higher utilization in Medicare Advantage and Medicaid. The Pharmacy & Consumer Wellness segment's revenues grew 3.7% to $29.8 billion, driven by increased prescription volume, while the Health Services segment revenues declined 8.8% to $42.2 billion following the loss of a large client.The company issued $5 billion in senior notes in May 2024 for general corporate purposes and repurchased 39.7 million shares for approximately $3 billion during H1 2024. CVS Health maintained its retail presence with over 9,000 locations and continued serving approximately 90 million pharmacy benefit manager plan members, though facing ongoing challenges from elevated Medicare utilization and Medicaid cost pressures.
西维斯健康报告称，2024年第二季度总收入增长了2.6%，达到912亿，主要受到医疗保健福利和药房及消费健康部门增长的推动，部分被医疗服务的下滑所抵消。归属于西维斯健康的净利润减少了6.9%，降至17.7亿，而摊薄后每股收益为1.41美元，较2023年第二季度的1.48美元有所下降。医疗保健福利部门的收入增长了21.4%，达到325亿，尽管其医疗福利比率从86.2%上升至89.6%，这是由于医疗保险优势计划和医疗补助的使用率增加。药房及消费健康部门的收入增长了3.7%，达到298亿，主要得益于处方成交量的增加，而医疗服务部门的收入下降了8.8%，降至422亿，原因是失去了一个大客户。公司于20...展开全部
西维斯健康报告称，2024年第二季度总收入增长了2.6%，达到912亿，主要受到医疗保健福利和药房及消费健康部门增长的推动，部分被医疗服务的下滑所抵消。归属于西维斯健康的净利润减少了6.9%，降至17.7亿，而摊薄后每股收益为1.41美元，较2023年第二季度的1.48美元有所下降。医疗保健福利部门的收入增长了21.4%，达到325亿，尽管其医疗福利比率从86.2%上升至89.6%，这是由于医疗保险优势计划和医疗补助的使用率增加。药房及消费健康部门的收入增长了3.7%，达到298亿，主要得益于处方成交量的增加，而医疗服务部门的收入下降了8.8%，降至422亿，原因是失去了一个大客户。公司于2024年5月发行了50亿的高级票据用于一般企业用途，并在2024年上半年回购了约3970万股，支出约30亿。西维斯健康维持了其零售业务，拥有超过9,000个网点，并继续为约9000万药房福利管理计划成员提供服务，尽管面临医疗保险使用率上升和医疗补助成本压力的持续挑战。

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

独立文件6  查看翻译

独立文件7  查看翻译

独立文件8  查看翻译

独立文件9  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    Alignment Healthcare
    ALHC
    -- 18.300
    信诺
    CI
    -- 325.040
    联合健康
    UNH
    -- 516.040
    Elevance Health
    ELV
    -- 432.000
    Molina Healthcare
    MOH
    -- 322.850
    解锁完整榜单
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。
    热门讨论
    中概股财报季火热：惊喜盈利能否延续涨势？
    1. 哪些行业可能成为本轮中概股财报季的市场焦点？ 2. 在政府强调科技创新和可持续发展的背景下，你认为哪些行业具有最大的增长潜力？ 展开
    中国两会：会议前后股票价格走势的主要要点